|

Arthritis Clinical Trials in Tucson, AZ

17 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study of SPY072 in Rheumatic DiseasePhase 23 mi
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and OsteoarthritisPhase 23 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 33 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 33 mi
Mobilizing Hispanics With Knee OsteoarthritisN/A3 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 33 mi
RA-PRO PRAGMATIC TRIALPhase 33 mi
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)Phase 23 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 33 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 33 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 33 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 23 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Phase 23 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 43 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 23 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseasePhase 33 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 13 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.